Iovance Biotherapeutics, Inc.
IOVA
$3.78
-$0.10-2.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.86% | -8.28% | -24.32% | -26.99% | 0.99% |
| Total Receivables | 15.25% | 18.90% | 19.71% | 89.65% | 30,215.38% |
| Inventory | -10.94% | 0.31% | 34.04% | 78.91% | 272.06% |
| Prepaid Expenses | -18.68% | -6.42% | 45.57% | 13.39% | 38.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.00% | -3.14% | -13.94% | -12.39% | 32.97% |
|
|
|||||
| Total Current Assets | -9.00% | -3.14% | -13.94% | -12.39% | 32.97% |
| Net Property, Plant & Equipment | 8.18% | 7.75% | -2.15% | -4.25% | -11.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.70% | -1.09% | -6.99% | 0.32% | -3.04% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 128.60% | 110.26% | 129.63% | 143.33% | -6.59% |
| Total Assets | -4.25% | 0.30% | -8.69% | -5.90% | 11.14% |
|
|
|||||
| Total Accounts Payable | 31.45% | -19.45% | -1.42% | 56.76% | 10.85% |
| Total Accrued Expenses | 7.76% | 39.26% | 13.94% | 29.87% | 73.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -58.95% | -60.89% | -36.97% | -29.43% | -14.25% |
| Total Finance Division Other Current Liabilities | -36.69% | -4.46% | 112.26% | 553.11% | 334.56% |
| Total Other Current Liabilities | -36.69% | -4.46% | 112.26% | 553.11% | 334.56% |
| Total Current Liabilities | 5.48% | 13.09% | 6.55% | 37.93% | 47.44% |
|
|
|||||
| Total Current Liabilities | 5.48% | 13.09% | 6.55% | 37.93% | 47.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.78% | 0.08% | -31.90% | -34.88% | -38.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.22% | -1.51% | -1.71% | 8.78% | -4.02% |
| Total Liabilities | 2.53% | 7.28% | -6.89% | 6.73% | 4.78% |
|
|
|||||
| Common Stock & APIC | 9.24% | 11.68% | 10.66% | 10.02% | 16.29% |
| Retained Earnings | -14.15% | -16.40% | -17.24% | -17.54% | -17.66% |
| Treasury Stock & Other | 100.99% | 1,671.70% | -0.86% | 3,865.59% | 5,325.86% |
| Total Common Equity | -6.01% | -1.66% | -9.20% | -9.11% | 12.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -33.33% | -33.33% | -33.33% | -33.33% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -33.33% | -33.33% | -33.33% | -33.33% |
|
|
|||||
| Total Common Equity | -6.01% | -1.66% | -9.20% | -9.11% | 12.92% |
| Total Preferred Equity | 0.00% | -33.33% | -33.33% | -33.33% | -33.33% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.01% | -1.66% | -9.20% | -9.11% | 12.92% |
|
|
|||||